EURUSD Bid: --
USDJPY Bid: --
GBPUSD Bid: --
USDCHF Bid: --
AUDUSD Bid: --
USDCAD Bid: --
NZDUSD Bid: --
EURGBP Bid: --
GBPJPY Bid: --
WTI Bid: --
BRENT Bid: --
XAUUSD Bid: --
XAGUSD Bid: --
SPX500 Bid: --
DAX40 Bid: --
US30 Bid: --
JPN225 Bid: --
NAS100 Bid: --
UK100 Bid: --
BTCUSD Bid: --
ETHUSD Bid: --
LTCUSD Bid: --
XRPUSD Bid: --
EURUSD Bid: --
USDJPY Bid: --
GBPUSD Bid: --
USDCHF Bid: --
AUDUSD Bid: --
USDCAD Bid: --
NZDUSD Bid: --
EURGBP Bid: --
GBPJPY Bid: --
WTI Bid: --
BRENT Bid: --
XAUUSD Bid: --
XAGUSD Bid: --
SPX500 Bid: --
DAX40 Bid: --
US30 Bid: --
JPN225 Bid: --
NAS100 Bid: --
UK100 Bid: --
BTCUSD Bid: --
ETHUSD Bid: --
LTCUSD Bid: --
XRPUSD Bid: --

A Token Is Only as Good as the Share Behind It: How Four Crypto Exchanges' SpaceX Bets Came Up Empty

Posted: 15th Jun 2026

Many platforms pushed tokenisation as a disruptor of the mainstream stock market structure. However, the recent cancellation of the tokenised SpaceX share allocations by four crypto exchanges, Binance, Bybit, Bitget Wallet and MEXC, has shown how thin that disruption can be when the asset behind the token refuses to materialise.

On 12 June, the same day SpaceX began trading on Nasdaq under the ticker SPCX, all four platforms scrapped their tokenised IPO campaigns and began refunding subscribers. Their explanation was near-identical: xStocks, the tokenised-equity platform they relied on to source the underlying shares, could not deliver.

Bybit told users it had received no allocation because xStocks failed to provide the assets. Binance cited circumstances beyond its control. Bitget Wallet said the allocation was simply not available as expected. MEXC, whose pre-IPO launchpad had been one of the most heavily subscribed of the group, followed with its own refunds.

Read more: Tokenised Stocks Are Here, but Do They Really Bring Added Value over CFDs?

Demand Was Never the Problem

The appetite for exposure was extraordinary. Binance's campaign had drawn more than $557 million in USDC from roughly 27,700 wallets before being halted, according to Dune Analytics data cited in industry reports. Retail dominated the book: subscribers committing under $20,000 each made up the bulk of participants, while at least 114 wallets staked more than $500,000 apiece.

MEXC's pre-IPO launchpad was oversubscribed 15.5 times, pulling in over 56 million USDT from more than 38,000 participants, over five times its previous record. Across the wider market, SpaceX's debut reportedly triggered upwards of $100 billion in retail demand.

That demand did not evaporate once the campaigns were pulled. Tokenised versions of the stock kept trading elsewhere: Backpack's SPCX token on Solana logged more than $35 million in volume within 24 hours, while pre-IPO perpetual futures on venues such as Hyperliquid had let traders bet on the listing days in advance.

The total market capitalisation of tokenised real-world assets sat above $5.5 billion by mid-2026, underlining how much money is now chasing on-chain exposure to traditional equities.

A Single Point of Failure

Supply, not demand, was the binding constraint. SpaceX's IPO was heavily oversubscribed across the board, and underwriters handed the crypto channel only a fraction of the shares it had taken orders for. The stock priced at $135, opened at $150, pushed past a $2 trillion valuation on its debut and touched an intraday high above $172 before closing its first session at $161.11. It ranked as the largest market debut on record. Tokenised subscribers watched the rally without owning a thing.

The failure traced back to one place. xStocks is not a neutral utility; it is the tokenised-equity arm Kraken acquired in December 2025 through its purchase of Backed Assets, the issuer of the underlying framework. Binance, Bybit, Bitget and MEXC were not sourcing SpaceX shares themselves. They were reselling access to allocations xStocks had promised to procure.

When that one supplier came up short, every platform hanging off it came up empty at the same moment. Kraken's own customers fared marginally better, receiving partial fills rather than nothing; one user reported a $5,078 order filled at roughly $607, with the balance returned. The squeeze was not even unique to crypto: data compiled by Access IPOs showed some retail clients at traditional brokerages also received only a portion of the shares they sought.

Tokenisation's Hard Limit

This is the uncomfortable lesson for an industry that has marketed tokenisation as a route around traditional market gatekeeping. Minting a token is trivial. Securing the real share that gives it value is not, and that part of the chain still runs through underwriters, custodians and allocation desks that crypto does not control.

xStocks had processed more than $25 billion in volume across over 100 tokenised stocks, yet that scale bought no leverage where it counted: at the IPO allocation table. The platforms' own fine print had always conceded the risk, with xStocks' disclaimers noting that its IPO tokens did not guarantee an allocation and offered price exposure only, not ownership.

Damage control followed quickly. Binance founder Changpeng Zhao said the priority was to protect users when things go wrong, and the exchange pledged a $1 million airdrop of SPCXB, a forthcoming token it says will be backed one-to-one by SpaceX shares held with a regulated custodian.

Bybit offered a consolation bonus pegged to a 10% annualised rate over a fixed window. Bitget Wallet refunded handling fees, whitelisted affected wallets for future listings and issued gas vouchers. MEXC processed refunds for its own subscribers.

The compensation does not change the structural point. Tokenisation proved it can manufacture demand and distribution at speed. It has not yet proved it can guarantee delivery of the assets it claims to represent, least of all for scarce, heavily contested instruments such as a blockbuster IPO. For all the talk of disrupting the stock market, the SpaceX cancellation left tokenised products hostage to the very system they were meant to bypass.

This article was written by Arnab Shome at www.financemagnates.com.

Source: Finance Magnates

Follow us on
Website Managed by BuiltByGo
Disclaimer: The information provided on FX Axe is for educational and informational purposes only and should not be construed as financial advice. Trading Foreign Exchange (FX), Contracts for Difference (CFDs), and other leveraged financial products involves a high level of risk and may not be suitable for all investors. Leverage can work both to your advantage and disadvantage, and as a result, you may lose more than your initial investment. Before deciding to trade FX, CFDs, or any other financial instrument, you should carefully consider your investment objectives, level of experience, and risk tolerance. You should not invest money that you cannot afford to lose. It is strongly advised that you seek independent financial advice if you have any doubts. FX Axe does not provide investment, tax, legal, or financial advice of any kind. We may receive compensation from brokers and partners featured on this website, but such relationships do not influence our reviews or recommendations. All reviews are based on our own opinions and research and should not be interpreted as endorsements or guarantees of any service. Past performance is not indicative of future results. The trading of FX and CFDs carries a significant risk of loss. By using this website, you acknowledge that FX Axe bears no responsibility for any losses you may incur from your trading activities or reliance on information provided here.

Affiliate Disclosure: Some of the links and references on FX Axe may relate to third-party brokers or service providers. In certain cases, we may receive compensation if you choose to engage with these providers through our website. This helps support the ongoing operation of the site and allows us to continue publishing content at no direct cost to our readers. Our content is created with the aim of being informative and useful. While commercial relationships may exist, we strive to ensure that the information presented remains objective and based on our own research and perspective.
cross